The da Vinci Surgical System (Intuitive Surgical, Inc, Sunnyvale, CA, USA) was approved by the U.S. Food and Drug Administration for the use in gynecologic procedures in 2005. The advantages of this epochal minimally invasive platform include high definition three-dimensional (3-D) camera of vision, instruments with wrist-like range of motion, surgeon’s tremor inhibition, better ergonomics, and a faster learning curve compared to traditional laparoscopy. This robotic assisted laparoscopic surgical system approves to be feasible, safe, and facilitates performing more complex, multiple intra-corporal suturing procedures. Currently the robotic assisted laparoscopy is mainly applied in hysterectomy, myomectomy, adnexal surgery, sarcro-colpopexy, endometriosis and tubal reanastomosis.
Robotic surgery obviously overcomes the bottle neck of traditional laparoscopy, and is embraced in gynecologic oncology widely and rapidly. The intraoperative benefits of the robotic technique include minimal blood loss, less adhesion formation and better visual perspective. Many patients with gynecologic cancers may benefit from robotic-assisted radical hysterectomy, robotic-assisted staging, evaluation, or a combination of them.
There is no question that the complication rate of robotic surgery is extremely low in the hands of experienced gynecologists. It has become a popular and widespread technique accepted by gynecologists as an appropriate alternative to conventional surgery in the management of patients with gynecologic diseases. |
